Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-25
2010-02-02
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S017000
Reexamination Certificate
active
07655670
ABSTRACT:
The present invention is directed to novel 3-spirocyclic indolyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the ORL-1 receptor.
REFERENCES:
patent: 2004/0152707 (2004-08-01), Tulshian et al.
patent: 2005/0038060 (2005-02-01), Ando et al.
patent: 2006/0079505 (2006-04-01), Makings et al.
Haynes et al. Stereoselective, Base-Induced Formation of Bicyclo[2.2.1] Heptanones and Bicyclo [3.2.1.] Octanols Formed from the Products of Conjugation Addition of Lithiated Allylic Sulfoxides and Phosphine Oxides to Cyclopean-2-enone. Australian Journal of Chemistry, Sep. 1989, vol. 42, No. 9, pp. 1473-1483, p. 1473, abstract.
Battista Kathleen A.
Bignan Gilles C.
Connolly Peter J.
Liu Jessica J.
Middleton Steven A.
Aulakh Charanjit S
Janssen Pharmaceutica N.V.
Kamage Andrea Jo
LandOfFree
3-spirocyclic indolyl derivatives useful as ORL-1 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-spirocyclic indolyl derivatives useful as ORL-1 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-spirocyclic indolyl derivatives useful as ORL-1 receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4229865